| Kevin Frederick Hanna, MD | |
|
200 1st St Sw, Rochester, MN 55905-0001 | |
| (507) 284-2511 | |
| Not Available |
| Full Name | Kevin Frederick Hanna |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Experience | 3 Years |
| Location | 200 1st St Sw, Rochester, Minnesota |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1821681461 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | 31514 (Minnesota) | Secondary |
| 208800000X | Urology | 71955 (Minnesota) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mayo Clinic Hospital Rochester | Rochester, MN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mayo Clinic | 6507778255 | 4232 |
News Archive
Scientists have shown how a parasitic worm infection common in the developing world increases susceptibility to tuberculosis. The study demonstrated that treating the parasite reduces lung damage seen in mice that also are infected with tuberculosis, thereby eliminating the vulnerability to tuberculosis (TB) that the parasite is known to cause.
The Female Health Company on Wednesday announced that FDA has approved its FC2 Female Condom to help prevent pregnancy and sexually transmitted infections such as HIV, the AP/Forbes reports.
A new tool for medical professionals may help shed more light on tumors in the body and how the brain operates.
One of the key questions, according to The Fiscal Times, is whether the premium subsidies available to people shopping on the federal exchange are legal.
Okana Ventures Inc. is pleased to announce the acquisition of the North American product rights for FACTIVE® (Gemifloxacin Mesylate) tablets from Merus Labs International for approximately US$3.4 million.
› Verified 2 days ago
| Entity Name | Mayo Clinic |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922074434 PECOS PAC ID: 6507778255 Enrollment ID: O20031103000285 |
News Archive
Scientists have shown how a parasitic worm infection common in the developing world increases susceptibility to tuberculosis. The study demonstrated that treating the parasite reduces lung damage seen in mice that also are infected with tuberculosis, thereby eliminating the vulnerability to tuberculosis (TB) that the parasite is known to cause.
The Female Health Company on Wednesday announced that FDA has approved its FC2 Female Condom to help prevent pregnancy and sexually transmitted infections such as HIV, the AP/Forbes reports.
A new tool for medical professionals may help shed more light on tumors in the body and how the brain operates.
One of the key questions, according to The Fiscal Times, is whether the premium subsidies available to people shopping on the federal exchange are legal.
Okana Ventures Inc. is pleased to announce the acquisition of the North American product rights for FACTIVE® (Gemifloxacin Mesylate) tablets from Merus Labs International for approximately US$3.4 million.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kevin Frederick Hanna, MD 200 1st St Sw, Rochester, MN 55905-0001 Ph: (507) 284-2511 | Kevin Frederick Hanna, MD 200 1st St Sw, Rochester, MN 55905-0001 Ph: (507) 284-2511 |
News Archive
Scientists have shown how a parasitic worm infection common in the developing world increases susceptibility to tuberculosis. The study demonstrated that treating the parasite reduces lung damage seen in mice that also are infected with tuberculosis, thereby eliminating the vulnerability to tuberculosis (TB) that the parasite is known to cause.
The Female Health Company on Wednesday announced that FDA has approved its FC2 Female Condom to help prevent pregnancy and sexually transmitted infections such as HIV, the AP/Forbes reports.
A new tool for medical professionals may help shed more light on tumors in the body and how the brain operates.
One of the key questions, according to The Fiscal Times, is whether the premium subsidies available to people shopping on the federal exchange are legal.
Okana Ventures Inc. is pleased to announce the acquisition of the North American product rights for FACTIVE® (Gemifloxacin Mesylate) tablets from Merus Labs International for approximately US$3.4 million.
› Verified 2 days ago
Dr. Javier Piraino, D.O Urology Medicare: Medicare Enrolled Practice Location: 200 1st St Sw, Rochester, MN 55905 Phone: 507-284-2511 | |
David E Patterson, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 200 1st St Sw, Rochester, MN 55905 Phone: 507-284-2511 | |
Dr. Vidit Sharma, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 200 1st St Sw, Rochester, MN 55905 Phone: 507-284-2511 | |
Tobias Steen Kohler, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 200 1st St Sw, Rochester, MN 55905 Phone: 507-284-2511 | |
Paige Elizabeth Nichols, Urology Medicare: Accepting Medicare Assignments Practice Location: 200 1st St Sw, Rochester, MN 55905 Phone: 507-284-2511 | |
Anessa Naomi Sax-bolder, MD Urology Medicare: Medicare Enrolled Practice Location: 200 1st St Sw, Rochester, MN 55905 Phone: 507-284-2511 | |
Dr. Aaron Mark Potretzke, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 200 1st St Sw, Rochester, MN 55905 Phone: 507-284-2511 |